Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
作者信息
Walsh J C, Costello C E, Nelson M R
出版信息
AIDS. 1997 Mar;11(3):399-400.
PMID:9147442
Abstract
摘要
相似文献
1
Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
AIDS. 1997 Mar;11(3):399-400.
2
3
4
5
[Lamivudine-zidovudine combination treatment].
Dtsch Med Wochenschr. 1996 Oct 4;121(40):A8, A11.
6
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS clinical trials group 229.
J Infect Dis. 1999 Jan;179(1):249-53. doi: 10.1086/314541.
7
Finding a role for zalcitabine in the HAART era.
Antivir Ther. 1998;3(3):125-37.
8
9
[Efficacy and tolerance of a combination of AZT, DDC, and saquinavir in patients infected with the human immunodeficiency virus].
Rev Clin Esp. 1998 Sep;198(9):634-5.
10
Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
AIDS. 2008 Jan 30;22(3):385-93. doi: 10.1097/QAD.0b013e3282f3f16d.
Zotero 插件